Latest News – 20 June 2025

World Blood Donor Day

Paul-Ehrlich-Institut Continuously Strengthens Blood Product Safety

#VaccineFacts

#VaccineFacts Continue Their Impact: The Paul-Ehrlich-Institut Provides Vaccine Information – Even Beyond the Digital Awareness Campaign

Veterinary Medicine

The Paul-Ehrlich-Institut Issued a Marketing Authorisation in Exceptional Circumstances in May 2025 for the Bultavo 3 Vaccine

Allergy Therapeutics

Regulatory Research: New Test Improves Quality Control of Allergy Therapeutics

Medicine Safety

Pharmacovigilance Report on the Use of COVID-19 Vaccines – Status as of 31 December 2024

FAQ: What should be taken into account when using public data on reports of suspected adverse events?

International Work

CHMP Meeting Highlights May 2025

PRAC Meeting Highlights May 2025

Information on the Topic of Vaccination Damages

The Paul-Ehrlich-Institut is not responsible for processing applications for recognition of vaccine damages.

The Paul-Ehrlich-Institut does not have any information, figures/data on vaccine damage procedures.

Recognition procedures for vaccination damages in accordance with section 24 of the Social Code (Sozialgesetzbuch, SGB) XIV are handled exclusively by the Social Welfare Office in the federal state in whose territory the vaccination was carried out. Sections 4, 5 and 113 of the SGB XIV provide information on the competent authority, compensation for official measures and payment obligations.

Important Short Links for Your Research

• Da­ta on suspected Ad­verse Drug Re­ac­tions
  www.pei.de/adr-data
• COVID-19 safety reports:
  www.pei.de/safety-covid-19-vaccines
• COVID-19 vaccines (with link to product information):
  www.pei.de/covid-19-vaccines
• Corona FAQ (including approval and development, efficacy and safety, batch testing and antigen testing):
  www.pei.de/faq-coronavirus-en
• Explainer videos as well as recordings of press briefings:
  www.youtube.com/channel/UC0GDU8v6JtuozYQqfjJN8bg/videos

top